Hypomagnesemia: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Diagnosis==" to "==Evaluation==") |
No edit summary |
||
| Line 29: | Line 29: | ||
##Furosemide | ##Furosemide | ||
##[[Hypophosphatemia]] | ##[[Hypophosphatemia]] | ||
#Type 2 Diabetes Mellitus <ref>[https://www.ncbi.nlm.nih.gov/pubmed/26696633 Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH. Hypomagnesemia in Type 2 Diabetes: A Vicious Circle? Diabetes. 2016 Jan;65(1):3-13.]</ref> | |||
==Management== | ==Management== | ||
Revision as of 18:36, 22 September 2016
Background
Evaluation
- CNS
- GI
- Dysphagia
- Cardiovascular
- CHF
- Dysrhythmias
- Hypotension
- Miscellaneous
Differential Diagnosis
- ETOH
- Malnutrition
- Cirrhosis
- Pancreatitis
- S/P DKA
- GI loss (esp diarrhea)
- Renal wasting
- Furosemide
- Hypophosphatemia
- Type 2 Diabetes Mellitus [1]
Management
- Serum level >1.7
- No treatment
- Serum level 1.2 - 1.7
- Serum level <1.2
- 4g MgSO4 IV over 2 hours
